logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Military Medical Academy

+381112661122
tcsnsl@vma.mod.gov.rs
Source: Site record.
http://www.vma.mod.gov.rs

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Military Medical Academy (VMA), Belgrade is one of the largest and most advanced tertiary-care academic medical institutions in Southeast Europe, with strong capabilities and infrastructure supporting clinical research across multiple therapeutic areas. As part of the Serbian Ministry of Defence and affiliated with the University of Defence’s medical faculty, it integrates clinical care, education, and scientific research, positioning it as a center of excellence in both military and civilian healthcare. From a clinical research perspective, VMA offers a highly developed ecosystem, including 26 clinics, 11 research institutes, specialized centers, and over 1,200 beds, enabling large-scale and complex clinical studies. Its dedicated Center for Clinical Pharmacology plays a key role in coordinating clinical trials, including bioequivalence studies, pharmacovigilance, and therapeutic drug monitoring, indicating structured involvement in regulated clinical research activities.…

Source: Trial-derived.
106Total Trials
Source: Trial-derived.
12Recruiting Trials
Source: Trial-derived.
35Active Trials
Source: Trial-derived.
55Completed Trials
Source: Trial-derived.
80Unique Conditions
Source: Trial-derived.
71Unique Sponsors

Conditions

Source: Trial-derived. Crohn's Disease (10)Source: Trial-derived. Ulcerative Colitis (8)Source: Trial-derived. Lupus Erythematosus, Systemic (5)Source: Trial-derived. Systemic Lupus Erythematosus (5)Source: Trial-derived. Crohn Disease (4)Source: Trial-derived. Diabetes Mellitus, Type 2 (3)Source: Trial-derived. Rheumatoid Arthritis (3)Source: Trial-derived. Ulcerative Colitis (UC) (3)

Sponsors

Source: Trial-derived. AbbVie (15)Source: Trial-derived. Hoffmann-La Roche (8)Source: Trial-derived. Amgen (7)Source: Trial-derived. Pfizer (6)Source: Trial-derived. Boehringer Ingelheim (5)Source: Trial-derived. Military Medical Academy, Belgrade, Serbia (4)Source: Trial-derived. Takeda (4)Source: Trial-derived. ACADIA Pharmaceuticals Inc. (3)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture
Source: AI-inferred. Electronic source (eSource) system

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. Spirometry
Source: AI-inferred. X-Ray
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. CT Scan
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. Standardised clinical photography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Invasive mechanical ventilation
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. Interferon-gamma release assay (IGRA) for tuberculosis
Source: AI-inferred. Stimulated salivary flow measurement (sialometry)
Source: AI-inferred. App-based insulin dose guidance
Source: AI-inferred. B-cell enumeration
Source: AI-inferred. Blood glucose meter monitoring
Source: AI-inferred. CD19-positive B-cell enumeration
Source: AI-inferred. Colonic mucosal biopsy